Two-million-year-old teeth unlock new secrets of ancient human relatives
Humans today have a diverse array of hominin distant relatives and ancestors from millions of years ago. The South African fossil record ranges from early hominins such as Australopithecus prometheus, A. africanus (Taung child), A. sediba and P. robustus, to early members of the genus Homo (H. erectus/ergaster, H. habilis), to later hominins such as H. naledi and Homo sapiens (humans).
Fossils show how these early relatives evolved from as far back as A. africanus, 3.67 million years ago. They also document milestones in evolution, including the transition to walking on two legs, tool making and increased brain development. Ultimately, our species – Homo sapiens – appeared in South Africa 153,000 years ago.
Fossils of P. robustus were first discovered in South Africa in 1938. But crucial questions remained. How much variation was there within the species? Were the size differences related to sex, or did they reflect the presence of multiple species? How was P. robustus related to the other hominins and early Homo? And what, genetically, made it distinct?
Until now, answers to these questions have been elusive. As a team of African and European molecular science, chemistry and palaeoanthropology researchers, we wanted to find answers but we couldn't use ancient DNA to help us. Ancient DNA has been a game-changer in studying later hominins like Neanderthals and Denisovans but it doesn't survive well in Africa's climate because of its simple structure.
We experienced a breakthrough when we decided to use palaeoproteomics – the analysis of ancient proteins. We extracted these from the enamel of the 2-million-year-old teeth of four P. robustus fossils from Swartkrans Cave in South Africa's Cradle of Humankind.
Luckily, proteins that are millions of years old preserve well because they stick to teeth and bones and are not affected by the warm weather. One of these proteins tells us the biological sex of the fossils. This is how we found that two of the individuals were male and two were female.
These findings open a new window into human evolution – one that could reshape how we interpret diversity in our early ancestors by providing some of the oldest human genetic data from Africa. From there, we can understand more about the relationships between the individuals and potentially even whether the fossils come from different species.
More than one kind of Paranthropus?
The protein sequences also revealed other subtle but potentially significant genetic differences. One standout difference was found in a gene which makes enamelin, a critical enamel-forming protein. We found that two of the individuals shared an amino acid with modern and early humans, chimpanzees and gorillas. The other two had an amino acid that among African great apes is, so far, unique to Paranthropus.
What's even more interesting is that one of the individuals had both the distinct amino acids. This is the first documented time we can show heterozygosity (a state of having two different versions of a gene) in proteins that are 2 million years old.
When studying proteins, specific mutations are thought to indicate different species. We were quite surprised to discover that what we initially thought was a mutation unique to Paranthropus robustus was actually variable within that group – some individuals had it while others did not. Again, this was the first time anyone had observed a protein mutation in ancient proteins (these mutations are usually observed in ancient DNA).
We realised that instead of seeing a single, variable species, we might be looking at a complex evolutionary puzzle of individuals with different ancestries. This shows that combining analyses of morphology (the study of the form and structure of organisms) and the study of ancient proteins, we can create a clearer evolutionary picture of the relationships among these early hominin individuals.
However, to confirm that P. robustus fossils have different ancestry, we will need to take samples of tooth enamel protein from more of their teeth. To do this, we plan to sustainably sample more P. robustus from other sites in South Africa where they've been found.
Preserving Africa's fossil heritage
Our team was careful to balance scientific innovation with the need to protect irreplaceable heritage. Fossils were sampled minimally, and all work followed South African regulations. We also involved local laboratories in the analysis. Many of the authors were from the African continent. They were instrumental in guiding the research agenda and approach from the early stages of the project.
Doing this kind of high-end science on African fossils in Africa is an important step towards transformation and decolonisation of palaeontology. It builds local capacity and ensures that discoveries benefit the regions from which the fossils come.
By combining data on molecules and morphology, our study offers a blueprint for future research – one that could clarify whether early hominins were more or less diverse than we've known.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
4 hours ago
- BBC News
Largest Mars rock ever sells for $4.3m at auction
An "unbelievably rare" piece of Mars - the largest ever found on Earth - has sold for $4.3m (£3.2m) at a New York auction on Wednesday. The meteorite, known as NWA 16788, weighs 54lb (24.5kg) and is nearly 15in (38.1cm) long, according to Sotheby's. It was discovered in a remote region of Niger in November 2023 and is 70% larger than the next biggest piece of Mars that has been recovered, the auction house said. Meteorites are whatever bits of rock are left after an asteroid or comet passes through Earth's atmosphere. Sotheby's auction house described the meteorite, a reddish brown rock, as "unbelievably rare". Only about 400 Martian meteorites have ever been found on Earth."This is the largest piece of Mars on planet Earth. The odds of this getting from there to here are astronomically small," Cassandra Hatton, vice-chairman of science and natural history at Sotheby's, said in a video posted online. "Remember that approximately 70% of Earth's surface is covered in water. So we're incredibly lucky that this landed on dry land instead of the middle of the ocean where we could actually find it."It remains unclear where the meteorite will end up as information about the sale will remain private. Additional taxes and fees brought the total price of the rock up to about $5.3m, Sotheby's said. At the Wednesday auction, which featured more than 100 items, a Ceratosaurus skeleton from the late Jurassic period sold for $26m and the skull of a Pachycephalosaurus sold for $1.4m.
The Independent
5 hours ago
- The Independent
Patients with penicillin allergy may benefit from further tests, study suggests
The majority of patients recorded as having a penicillin allergy may not be truly allergic to the antibiotic, a first-of-its-kind trial suggests. Those with the marker on their medical records could benefit from tests to confirm or rule out an allergy, according to researchers. Removing incorrect labels could help improve care for patients while tackling antibiotic resistance and saving money for the NHS, they said. For the Alabama trial, published in the Lancet Primary Care and led by the University of Leeds, researchers recruited 823 patients from 51 GP practices in England. Those taking part had no history of severe reactions to penicillin. Some patients were tested for a penicillin allergy, with either an oral dose of the antibiotic or a small injection under the skin. If there was no immediate reaction, patients were given a three-day course of penicillin to take at home, where they were monitored by the research team. Of the 365 people tested for an allergy, some 234 had an oral test, with 13 testing positive, while 131 had a skin test, three of which were positive. Elsewhere, 128 patients had an oral test after a skin test, with 14 testing positive for an allergy. Overall, the study found 30 patients tested positive for a penicillin allergy, while 335 – or 92% – tested negative. After three months, 276 patients had the allergy removed from their medical records. And after 12 months, allergies were removed from the records of 321 patients, or 88% of the group that was tested. Dr Jonathan Sandoe, lead author and associate clinical professor in microbiology at the University of Leeds School of Medicine and Leeds Teaching Hospitals NHS Trust, said: 'Antibiotics have been life-saving drugs since the late 1930s, but we are now in an era where microbes are evolving to resist the effects of current antibiotics. 'The global challenge of antibiotic resistance is causing people to die of common infections, so it is vital to find ways to improve how antibiotics are used. 'Assessing people with penicillin allergy labels is one way we can achieve this.' Patients who had the allergy check also had fewer antibiotics overall, the study suggests. As part of the study, researchers analysed the cost-effectiveness of allergy testing based on the NHS model. They said that although results may vary in different countries, the study observed 'tendency towards reducing consultations, days in hospital, and emergency admissions' which 'suggest that the penicillin allergy assessment pathway is cost-effective in the short run and increasingly likely to be so over longer follow-up periods'. Researchers now suggest that 'access to penicillin allergy assessment for patients should be widened'. Dr Sandoe added: 'This research shows that removing incorrect penicillin allergy labels has the potential to improve patient experiences, reduce health costs and tackle bacterial resistance. 'Now, we need to work together with policymakers and patients to help the NHS to address this issue.' Professor Sue Pavitt from the University of Leeds, who jointly led the study, said her mother Rosie Woollard had a penicillin allergy added to her medical records in the 1950s. She had been prescribed the antibiotic for mastitis – a common infection usually linked with breastfeeding – and developed a rash. Prof Pavitt said: 'My mum was vigilant and avoided taking penicillin from that day, but her allergy was never checked. 'It may have been a simple reaction to the other substances used in manufacturing the tablet or her rash was just a consequence of the infection. 'When my mum got older and had more underlying health problems, we noticed that when she had an infection, she often needed two or three courses of different antibiotics before the infection would clear. 'Each round of antibiotics took a toll on her wellbeing, appetite and ability to bounce back until the infection was under control.' Ms Woollard developed repeated urinary tract infections later in life and died at the age of 91. Her cause of death was recorded as an antimicrobial infection. Prof Pavitt said: 'Antibiotic allergy and resistant bugs are complex concepts to understand – she was our barometer to see if we were explaining things clearly. 'She was also instrumental in making the Alabama trial open to older people with multiple long-term conditions, a group that is often excluded from research but important to reach. 'This research is in part her legacy and shows the value of preserving antibiotics, so that we can keep fighting infections with these important medicines.' Christopher Butler, a professor of primary care in the Nuffield department of primary care health sciences at the University of Oxford, said: 'It's this kind of research question that has a huge impact on improving care for individuals, improving cost-effectiveness of what we do as clinicians, and helps us preserve the precious shared resource of of antibiotics to all of us and to future generations.'
Telegraph
5 hours ago
- Telegraph
First ‘three-parent' babies found healthy in scientific breakthrough
Eight healthy babies with the DNA of three people have been born in Britain in a groundbreaking first hailed as a 'scientific tour-de-force.' Dubbed 'three parent babies', the infants carry the genetic material of a 'second mother' to repair damage in their mitochondrial DNA, which powers the cells. British scientists have spent decades perfecting the technique, which involves transplanting nuclear DNA – containing all the characteristics of a person – into a donor egg with healthy mitochondria. Scientists hope the breakthrough can help women whose children would be at risk of mitochondrial disease. Every year around one in 5,000 children are born with mitochondrial mutations in Britain, while 12,000 are living with a mitochondrial disorder. These can lead to serious problems such as heart and liver failure, blindness, deafness, diabetes, respiratory problems and even death. After following the infants for up to two years, scientists announced on Wednesday that the technique works and all the babies are healthy. Professor Sir Doug Turnbull, Emeritus Professor of Neurology, at Newcastle University, who led the team said: 'I think everybody knows I'm a natural pessimist, so it's a relief. 'Mitochondrial disease can have a devastating impact on families. Today's news offers fresh hope to many more women at risk of passing on this condition who now have the chance to have children growing up without this terrible disease.' The disease is passed down solely from the mother, and there is no cure, but in the late 1990s, scientists began to question whether the defective mitochondria could be replaced with healthy donor DNA. While nuclear DNA is the blueprint for the entire cell, comprising around 3.3 billion base pairs, mitochondrial DNA only codes for energy production and is built from around 16,000 base pairs. Nevertheless, the idea proved controversial, with both the Church of England and the Catholic Church in England and Wales questioning whether the technique was safe or ethical. Experts from the Zoological Society of London warned that in 50 per cent of animal studies, faulty mitochondrial DNA had been transferred over during the procedure, while the US Food and Drug Administration deemed the process unsafe. In spite of the objections, Parliament approved new legislation to allow the procedure in 2015, and the first licence was granted in 2017 to Newcastle Fertility Centre, which pioneered the technique. The procedure involves transplanting the nuclear DNA - which contains all the genes that make up individual characteristics –from a fertilised egg to an egg donated by an unaffected woman which has had its nuclear DNA removed. The resulting embryo inherits its parents' nuclear DNA, but the mitochondrial DNA is inherited predominantly from the donated egg. Early attempts failed and it was not until 2023 that Freedom of Information requests showed the first baby had been born in Newcastle by these methods. At the time, researchers were reluctant to discuss the case, leading to fears the child had not survived. Now, two years on, scientists say the infant is growing well and has passed all developmental milestones. Seven other children have also been born through the process without any major complications, and all eight babies show no signs of having mitochondrial DNA disease. Prof Bobby McFarlane, Professor of Paediatric Mitochondrial Medicine at Newcastle University said: 'All the children are well and they are continuing to meet their developmental milestones. 'While longer term follow-up of children born following mitochondrial donation is of paramount importance, these early results are very encouraging. 'Seeing the joy and relief these children have brought to their parents is such a privilege.' Life and possibility The parents did not want to be named but said they were 'overwhelmed with gratitude', and thankful to the scientists who allowed them to conceive healthy children. One mother of a baby girl born following mitochondrial donation said: ' After years of uncertainty this treatment gave us hope –and then it gave us our baby. 'We look at them now, full of life and possibility, and we're overwhelmed with gratitude. Science gave us a chance.' The mother of a baby boy added: 'This breakthrough has lifted the heavy cloud of fear that once loomed over us. Our little family is complete.' Scientists hope the breakthrough can help around 150 women a year. Unlike with egg or sperm donors, children are not entitled to know the details of their mitochondrial donor unless they have agreed to share the information. However in some cases friends or family members have donated their DNA. Commenting on the research Dusko Ilic, Professor of Stem Cell Science, King's College London, said the healthy births were 'a remarkable accomplishment'. Dr Andy Greenfield, Honorary Fellow at the Nuffield Department of Women's & Reproductive Health at the University of Oxford, added: 'It is a triumph of scientific innovation in the IVF clinic – a world-first that shows that the UK is an excellent environment in which to push boundaries in IVF. A baby was born in 2016 in Mexico using a similar technique developed by British researchers, but it is not known if the child survived.
